- Home
- ROIV vs REXR Comparison
ROIV vs REXR Comparison
Compare ROIV & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- REXR
- Stock Information
- Founded
- ROIV 2014
- REXR 2013
- Country
- ROIV United Kingdom
- REXR United States
- Employees
- ROIV N/A
- REXR N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- REXR Real Estate Investment Trusts
- Sector
- ROIV Health Care
- REXR Real Estate
- Exchange
- ROIV Nasdaq
- REXR Nasdaq
- Market Cap
- ROIV 7.8B
- REXR 7.7B
- IPO Year
- ROIV N/A
- REXR 2013
- Fundamental
- Price
- ROIV $10.99
- REXR $35.22
- Analyst Decision
- ROIV Buy
- REXR Hold
- Analyst Count
- ROIV 4
- REXR 9
- Target Price
- ROIV $17.50
- REXR $39.67
- AVG Volume (30 Days)
- ROIV 5.1M
- REXR 2.7M
- Earning Date
- ROIV 05-29-2025
- REXR 07-16-2025
- Dividend Yield
- ROIV N/A
- REXR 4.88%
- EPS Growth
- ROIV N/A
- REXR 12.67
- EPS
- ROIV N/A
- REXR 1.23
- Revenue
- ROIV $29,053,000.00
- REXR $974,598,000.00
- Revenue This Year
- ROIV N/A
- REXR $9.78
- Revenue Next Year
- ROIV N/A
- REXR $8.46
- P/E Ratio
- ROIV N/A
- REXR $28.67
- Revenue Growth
- ROIV N/A
- REXR 18.04
- 52 Week Low
- ROIV $8.73
- REXR $29.68
- 52 Week High
- ROIV $13.06
- REXR $52.61
- Technical
- Relative Strength Index (RSI)
- ROIV 52.59
- REXR 52.31
- Support Level
- ROIV $10.59
- REXR $33.82
- Resistance Level
- ROIV $11.37
- REXR $36.93
- Average True Range (ATR)
- ROIV 0.32
- REXR 0.82
- MACD
- ROIV -0.01
- REXR 0.12
- Stochastic Oscillator
- ROIV 52.23
- REXR 45.02
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.